Autodesk Inc vs Twist Bioscience Corp — how do they compare? Autodesk Inc trades at $247.5 (market cap $53.12B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Autodesk Inc is far larger — about 6.9× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Autodesk Inc nearer its low. Which is the better fit depends on your goals.
| ADSK | TWST | |
|---|---|---|
Market Cap | $53.12B | $7.72B |
Sector | Technology | Health |
52-Week High | $326.79 | $124.88 |
52-Week Low | $187.72 | $24.16 |
Enterprise Value | $52.92B | $7.65B |
Trailing returns across standard periods
Founded in 1982, Autodesk is an application software company that serves industries in architecture, engineering, and construction.
Read more on ADSK →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →